BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 15537825)

  • 1. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear.
    Stiedl O; Meyer M; Jahn O; Ogren SO; Spiess J
    J Pharmacol Exp Ther; 2005 Mar; 312(3):905-16. PubMed ID: 15537825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety.
    Todorovic C; Radulovic J; Jahn O; Radulovic M; Sherrin T; Hippel C; Spiess J
    Eur J Neurosci; 2007 Jun; 25(11):3385-97. PubMed ID: 17553007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
    Tovote P; Meyer M; Beck-Sickinger AG; von Hörsten S; Ove Ogren S; Spiess J; Stiedl O
    Regul Pept; 2004 Aug; 120(1-3):205-14. PubMed ID: 15177939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
    Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
    Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
    de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
    J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate dynamics and behavioral responses during acute emotional challenge in corticotropin-releasing factor receptor 1-deficient and corticotropin-releasing factor-overexpressing mice.
    Tovote P; Meyer M; Ronnenberg A; Ogren SO; Spiess J; Stiedl O
    Neuroscience; 2005; 134(4):1113-22. PubMed ID: 16039799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning.
    Sherrin T; Blank T; Saravana R; Rayner M; Spiess J; Todorovic C
    Neuroscience; 2009 Aug; 162(1):14-22. PubMed ID: 19362130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of CRF2 receptor antagonists on rat conditioned fear responses and c-Fos and CRF expression in the brain limbic structures.
    Skórzewska A; Lehner M; Hamed A; Wisłowska-Stanek A; Turzyńska D; Sobolewska A; Płaźnik A
    Behav Brain Res; 2011 Aug; 221(1):155-65. PubMed ID: 21376756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The localization of brain sites of anxiogenic-like effects of urocortin-2.
    Skórzewska A; Bidziński A; Lehner M; Turzyńska D; Sobolewska A; Wisłowska-Stanek A; Maciejak P; Szyndler J; Płaźnik A
    Neuropeptides; 2011 Feb; 45(1):83-92. PubMed ID: 21168912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
    Staub DR; Evans AK; Lowry CA
    Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central stresscopin modulates cardiovascular function through the adrenal medulla in conscious rats.
    Chu CP; Qiu DL; Kato K; Kunitake T; Watanabe S; Yu NS; Nakazato M; Kannan H
    Regul Pept; 2004 Jun; 119(1-2):53-9. PubMed ID: 15093697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats.
    Muramatsu T; Inoue K; Iwasaki S; Yamauchi T; Hayashi T; Kiriike N
    Pharmacol Biochem Behav; 2006 Oct; 85(2):435-40. PubMed ID: 17109941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat.
    Inoue K; Valdez GR; Reyes TM; Reinhardt LE; Tabarin A; Rivier J; Vale WW; Sawchenko PE; Koob GF; Zorrilla EP
    J Pharmacol Exp Ther; 2003 Apr; 305(1):385-93. PubMed ID: 12649393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2.
    Radulovic J; Rühmann A; Liepold T; Spiess J
    J Neurosci; 1999 Jun; 19(12):5016-25. PubMed ID: 10366634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine.
    Todorovic C; Jahn O; Tezval H; Hippel C; Spiess J
    Neurosci Biobehav Rev; 2005; 29(8):1323-33. PubMed ID: 16099044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of CRF and alpha-helical CRF(9-41) on rat fear responses, c-Fos and CRF expression, and concentration of amino acids in brain structures.
    Skórzewska A; Bidziński A; Hamed A; Lehner M; Turzyńska D; Sobolewska A; Maciejak P; Szyndler J; Wisłowska-Stanek A; Płaźnik A
    Horm Behav; 2008 Nov; 54(5):602-12. PubMed ID: 18601929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional hemodynamic actions of selective corticotropin-releasing factor type 2 receptor ligands in conscious rats.
    Gardiner SM; March JE; Kemp PA; Davenport AP; Wiley KE; Bennett T
    J Pharmacol Exp Ther; 2005 Jan; 312(1):53-60. PubMed ID: 15328375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat.
    Sajdyk TJ; Fitz SD; Shekhar A
    Stress; 2006 Mar; 9(1):21-8. PubMed ID: 16753930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.